Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

BACKGROUND: The current literature recognises that left ventricular hypertrophy makes a key contribution to the high rate of premature cardiovascular mortality in dialysis patients. Determining how we might intervene to ameliorate left ventricular hypertrophy in dialysis populations has become a res...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunlop, Joanna Leigh, Vandal, Alain Charles, de Zoysa, Janak Rashme, Gabriel, Ruvin Sampath, Haloob, Imad Adbi, Hood, Christopher John, Matheson, Philip James, McGregor, David Owen Ross, Rabindranath, Kannaiyan Samuel, Semple, David John, Marshall, Mark Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720185/
https://www.ncbi.nlm.nih.gov/pubmed/23855560
http://dx.doi.org/10.1186/1471-2369-14-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720185/
https://www.ncbi.nlm.nih.gov/pubmed/23855560
http://dx.doi.org/10.1186/1471-2369-14-149

Ejemplares similares